HSV-1 ICP35 Antibodies

Santa Cruz Biotechnology provides a broad selection of HSV-1 ICP35 monoclonal antibodies for advanced research in virology and molecular biology. HSV-1 ICP35 monoclonal antibodies demonstrate high effectiveness in various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). HSV-1 ICP35 plays a crucial role in the viral life cycle, functioning as a key component in the regulation of viral gene expression and replication. Understanding the mechanisms of HSV-1 ICP35 is essential for developing therapeutic strategies against herpes simplex virus infections, which can lead to significant morbidity. The study of HSV-1 ICP35 contributes to the broader understanding of viral pathogenesis and host interactions. Researchers worldwide utilize HSV-1 ICP35 monoclonal antibodies to uncover new insights into viral mechanisms and potential therapeutic targets. Advanced research techniques incorporating HSV-1 ICP35 monoclonal antibodies enable detailed investigation of viral protein dynamics and interactions. Santa Cruz Biotechnology monoclonal antibodies for HSV-1 ICP35 support the scientific community in advancing viral research and therapeutic development.